See more : Absolute Software Corporation (ABST) Income Statement Analysis – Financial Results
Complete financial analysis of TriplePoint Venture Growth BDC Corp. (TPVG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of TriplePoint Venture Growth BDC Corp., a leading company in the Asset Management industry within the Financial Services sector.
- Koninklijke Brill NV (BRILL.AS) Income Statement Analysis – Financial Results
- Zhejiang grandwall electric science&technology co.,ltd. (603897.SS) Income Statement Analysis – Financial Results
- Modern Dental Group Limited (3600.HK) Income Statement Analysis – Financial Results
- Bansal Roofing Products Limited (BRPL.BO) Income Statement Analysis – Financial Results
- Fujian Longking Co., Ltd. (600388.SS) Income Statement Analysis – Financial Results
TriplePoint Venture Growth BDC Corp. (TPVG)
About TriplePoint Venture Growth BDC Corp.
TriplePoint Venture Growth BDC Corp. is a business development company specializing investments in venture capital-backed companies at the growth stage investments. It also provides debt financing to venture growth space companies which includes growth capital loans, secured and customized loans, equipment financings, revolving loans and direct equity investments. The fund seeks to invest in e-commerce, entertainment, technology and life sciences sector. Within technology the areas of focus include: Security, wireless communication equipments, network system and software, business applications software, conferencing equipments/services .big data, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, software, software as a service, and other technology related subsectors and within life sciences the areas of focus include: biotechnology, bio fuels/bio mass, diagnostic testing and bioinformatics, drug delivery, drug discovery, healthcare information systems, healthcare services, medical, surgical and therapeutic devices, pharmaceuticals and other life science related subsectors. Within growth capital loans it invests between $5 million and $50 million, for equipment financings it invests between $5 million and $25 million, for revolving loans it invests between $1 million and $25 million, and for direct equity investments it may invest between $0.1 million and $5 million (generally not exceeding 5% of the company's total equity). The debt financing products are typically structured as lines of credit and it invests through warrants and secured loans. It targeted returns between 10% and 18%. It does not take board seat in the company.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 61.73M | 119.42M | 83.37M | 42.00M | 40.20M | 41.53M | 24.64M | 15.59M | 22.54M | 29.94M |
Cost of Revenue | -75.76M | 24.66M | 24.79M | 23.26M | 18.47M | 15.62M | 13.29M | 9.85M | 11.01M | 0.00 |
Gross Profit | 137.49M | 94.76M | 58.58M | 18.74M | 21.73M | 25.91M | 11.35M | 5.74M | 11.53M | 29.94M |
Gross Profit Ratio | 222.74% | 79.35% | 70.26% | 44.62% | 54.05% | 62.40% | 46.08% | 36.81% | 51.15% | 100.00% |
Research & Development | 0.00 | -0.27 | 1.14 | 0.35 | 0.44 | 0.55 | 0.37 | 0.49 | 0.00 | 0.00 |
General & Administrative | 9.00M | 6.70M | 6.13M | 6.70M | 6.04M | 4.96M | 4.30M | 4.47M | 4.35M | 10.37M |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 9.00M | 6.70M | 6.13M | 6.70M | 6.04M | 4.96M | 4.30M | 4.47M | 4.35M | 10.37M |
Other Expenses | -36.07M | 51.42M | 681.00K | 38.76M | 2.40M | 2.55M | 3.63M | 2.58M | 2.67M | 0.00 |
Operating Expenses | -27.07M | 6.70M | 6.81M | 6.70M | 8.44M | 4.96M | 5.41M | 4.47M | 7.02M | 8.12M |
Cost & Expenses | -27.07M | 55.87M | 6.81M | 6.70M | 8.44M | 18.54M | 16.18M | 12.77M | 14.14M | 8.12M |
Interest Income | 133.25M | 116.57M | 82.83M | 88.57M | 70.52M | 62.61M | 50.04M | 41.77M | 39.90M | 4.68M |
Interest Expense | 33.04M | 26.76M | 17.37M | 15.49M | 10.01M | 9.08M | 9.06M | 7.86M | 3.62M | 0.00 |
Depreciation & Amortization | 0.00 | 66.73M | -27.22M | 48.93M | 28.60M | 29.75M | 31.01M | 11.79M | -2.82M | -20.05M |
EBITDA | 0.00 | 0.00 | 0.00 | -12.55M | -6.50M | 45.64M | 28.29M | 18.99M | 19.14M | -5.76M |
EBITDA Ratio | 0.00% | 68.61% | 91.83% | 84.06% | 79.00% | 103.78% | 104.60% | 105.25% | 84.92% | -9.67% |
Operating Income | 73.81M | 90.32M | 76.56M | 35.31M | 31.76M | 34.99M | 26.27M | 23.01M | 21.96M | 20.05M |
Operating Income Ratio | 119.57% | 75.63% | 91.83% | 84.06% | 79.00% | 84.26% | 106.60% | 147.59% | 97.43% | 66.95% |
Total Other Income/Expenses | -113.63M | -62.13M | -3.06M | 23.26M | -14.09M | 1.57M | -7.04M | -11.89M | 0.00 | -5.28M |
Income Before Tax | -39.82M | -20.07M | 76.56M | 35.31M | 31.76M | 36.56M | 19.23M | 11.13M | 15.52M | 17.15M |
Income Before Tax Ratio | -64.51% | -16.81% | 91.83% | 84.06% | 79.00% | 88.05% | 78.03% | 71.36% | 68.87% | 57.28% |
Income Tax Expense | 0.00 | 26.76M | 40.42M | 47.85M | 38.25M | 7.95M | 29.40M | 18.99M | 296.00K | -2.90M |
Net Income | -39.82M | -46.83M | 76.56M | 35.31M | 31.76M | 36.56M | 19.23M | 11.13M | 15.52M | 17.15M |
Net Income Ratio | -64.51% | -39.21% | 91.83% | 84.06% | 79.00% | 88.05% | 78.03% | 71.36% | 68.87% | 57.28% |
EPS | -1.12 | -1.43 | 2.47 | 1.16 | 1.28 | 1.78 | 1.18 | 0.69 | 1.03 | 1.74 |
EPS Diluted | -1.12 | -1.43 | 2.47 | 1.16 | 1.28 | 1.78 | 1.18 | 0.69 | 1.03 | 1.74 |
Weighted Avg Shares Out | 35.71M | 32.69M | 30.94M | 30.57M | 24.84M | 20.49M | 16.32M | 16.16M | 15.04M | 9.87M |
Weighted Avg Shares Out (Dil) | 35.71M | 32.69M | 30.94M | 30.57M | 24.84M | 20.49M | 16.32M | 16.16M | 15.04M | 9.87M |
TriplePoint Venture Growth: Don't Get Caught Going Down With The Ship
TriplePoint Venture Growth: 25% Dividend Cut - What To Do Now?
TriplePoint Venture: New Distribution Looks Unsustainable As Well
TriplePoint Venture: Disappointing Q2 Earnings Results In Distribution Cut
TriplePoint Venture Growth (TPVG) Q2 Earnings and Revenues Lag Estimates
TriplePoint Venture Growth (TPVG) Q2 2024 Earnings Call Transcript
Strength Seen in TriplePoint Venture Growth (TPVG): Can Its 6.2% Jump Turn into More Strength?
I Am Earning 19% Yield On My Latest Buy: TriplePoint Venture
Readers Identify 30 Ideal June Dividend Buys Out Of 40 Nods
3 Business Development Companies Yielding Over 5%
Source: https://incomestatements.info
Category: Stock Reports